Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Brain Glioma
  • Congenital Hyperinsulinism
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Parkinson Disease
Type
Interventional
Phase
Phase 3
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Diagnostic

Participation Requirements

Age
Younger than 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03042416
Collaborators
Alberta Health Services
Investigators
Principal Investigator: Jonathan T Abele, MD University of Alberta